HD5

General Information


DRACP ID  DRACP00805

Peptide Name   HD5

Sequence  ATCYCRTGRCATRESLSGVCEISGRLYRLCCR

Sequence Length  32

UniProt ID  Not available

PubChem CID  Not available

Origin  Homo sapiens

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
JLTRG (Jurkat LTR-GFP Cells) Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia Not active up to 50 µg/ml CCK-8 assay 36h 1

Hemolytic Activity  Human erythrocytes: NA; Mouse erythrocytes: 20% Hemolysis=25 µg/ml; 33% Hemolysis=50 µg/ml; 40% Hemolysis=100 µg/ml

Normal (non-cancerous) Cytotoxicity  HaCat: 10% Killing=150 µg/ml; ARPE-19: 50% Cytotoxicity=24 µM; CaSki: Not active up to 50 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00805

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C144H244N50O45S6

Absent amino acids  DFHKMNPQW

Common amino acids  CR

Mass  414131

Pl  8.62

Basic residues  6

Acidic residues  2

Hydrophobic residues  7

Net charge  4

Boman Index  -8349

Hydrophobicity  -11.25

Aliphatic Index  64.06

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  3355

Absorbance 280nm  108.23

Polar residues  17

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23269800

Title  Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites

Doi 10.1128/JVI.02209-12

Year  2013

Literature 2

Pubmed ID 29158275

Title  A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii

Doi 10.1128/AAC.01504-17

Year  2018

Literature 3

Pubmed ID 32209394

Title  The human α-defensin-derived peptide HD5(1-9) inhibits cellular attachment and entry of human cytomegalovirus

Doi 10.1016/j.antiviral.2020.104779

Year  2020

Literature 4

Pubmed ID 26206286

Title  Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs

Doi 10.1016/j.peptides.2015.07.009

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.